Harvest Fund Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1
Closed 540
2026
Q1
$0 Hold
1
﹤0.01% 592
2025
Q4
$0 Sell
1
-537
-100% -$137K ﹤0.01% 669
2025
Q3
$147K Hold
538
0.01% 357
2025
Q2
$139K Buy
538
+528
+5,280% +$126K 0.01% 353
2025
Q1
$2K Sell
10
-1,646
-99% -$384K ﹤0.01% 639
2024
Q4
$379K Buy
1,656
+665
+67% +$160K 0.02% 376
2024
Q3
$242K Sell
991
-315
-24% -$70.4K 0.01% 321
2024
Q2
$250K Sell
1,306
-1,556
-54% -$316K 0.02% 314
2024
Q1
$567K Buy
+2,862
New +$524K 0.05% 197
2023
Q3
Sell
-81
Closed -$18K 702
2023
Q2
$18K Sell
81
-195
-71% -$43.5K ﹤0.01% 516
2023
Q1
$60K Buy
+276
New +$59.9K 0.01% 447
2022
Q4
Sell
-426
Closed -$93K 843
2022
Q3
$93K Hold
426
0.03% 314
2022
Q2
$89K Hold
426
0.02% 322
2022
Q1
$103K Sell
426
-995
-70% -$241K 0.02% 343
2021
Q4
$372K Buy
1,421
+221
+18% +$57.3K 0.06% 136
2021
Q3
$316K Sell
1,200
-132
-10% -$36.1K 0.07% 92
2021
Q2
$330K Hold
1,332
0.04% 91
2021
Q1
$258K Sell
1,332
-400
-23% -$80.2K 0.03% 118
2020
Q4
$368K Buy
1,732
+174
+11% +$34.7K 0.03% 92
2020
Q3
$266K Hold
1,558
0.02% 124
2020
Q2
$297K Sell
1,558
-359
-19% -$58.7K 0.03% 106
2020
Q1
$282K Buy
1,917
+862
+82% +$137K 0.03% 100
2019
Q4
$167K Buy
1,055
+489
+86% +$70.5K 0.02% 126
2019
Q3
$76K Buy
+566
New +$74.2K 0.01% 225
2019
Q1
Sell
-905
Closed -$103K 384
2018
Q4
$103K Hold
905
0.02% 180
2018
Q3
$104K Buy
905
+643
+245% +$70.4K 0.02% 267
2018
Q2
$27K Buy
+262
New +$26.5K ﹤0.01% 275

Other funds holding RMD

Harvest Fund Management's RMD Position: Q2 2026 in Review

Harvest Fund Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 1 share.

Harvest Fund Management first reported a position in RMD in Q2 2018 and held it in 27 quarters. The position peaked at $567K in Q1 2024. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Harvest Fund Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Harvest Fund Management sold 1 ResMed share in Q2 2026.
  • Harvest Fund Management first reported a position in ResMed in Q2 2018 and held it in 27 quarters.
  • Harvest Fund Management's ResMed position peaked at $567K in Q1 2024.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Harvest Fund Management's 13F filing for Q2 2026, filed 20 Aug 2026.